Clinical-stage biotechnology company discovering & developing targeted therapies disrupting the efficacy-toxicity trade-off.
RS Research has raised $109K in total funding. The most recent round was Grant. The last funding was announced in March 2024.
RS Research's investors include European Innovation Council, Eczacıbaşı Momentum, ACT Venture Partners, Gen Pharmaceuticals, İstanbul Portföy Yönetimi.
RS Research is headquartered in Istanbul, Turkey.
Clinical-stage biotechnology company discovering & developing targeted therapies disrupting the efficacy-toxicity trade-off.
RS Research is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"RS Research — Funding & Investors." VCBacked, March 18, 2024, https://www.vcbacked.co/company/rs-research. Accessed September 15, 2026.
VCBacked. (2024). RS Research — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/rs-research
{{cite web |title=RS Research — Funding & Investors |url=https://www.vcbacked.co/company/rs-research |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated